179 related articles for article (PubMed ID: 8380614)
1. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.
Olmsted SL; Takemori AE; Portoghese PS
J Med Chem; 1993 Jan; 36(1):179-80. PubMed ID: 8380614
[No Abstract] [Full Text] [Related]
2. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
3. Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole.
Portoghese PS; Nagase H; MaloneyHuss KE; Lin CE; Takemori AE
J Med Chem; 1991 May; 34(5):1715-20. PubMed ID: 1851846
[TBL] [Abstract][Full Text] [Related]
4. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
Rogers H; Hayes AG; Birch PJ; Traynor JR; Lawrence AJ
J Pharm Pharmacol; 1990 May; 42(5):358-9. PubMed ID: 1976787
[TBL] [Abstract][Full Text] [Related]
5. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
Portoghese PS; Sultana M; Takemori AE
J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
[TBL] [Abstract][Full Text] [Related]
6. Opioid agonist and antagonist activities of morphindoles related to naltrindole.
Portoghese PS; Larson DL; Sultana M; Takemori AE
J Med Chem; 1992 Nov; 35(23):4325-9. PubMed ID: 1333013
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.
Ananthan S; Kezar HS; Saini SK; Khare NK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem Lett; 2003 Feb; 13(3):529-32. PubMed ID: 12565965
[TBL] [Abstract][Full Text] [Related]
8. The role of the side chain in determining relative delta- and kappa-affinity in C5'-substituted analogues of naltrindole.
Black SL; Jales AR; Brandt W; Lewis JW; Husbands SM
J Med Chem; 2003 Jan; 46(2):314-7. PubMed ID: 12519069
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and delta-opioid receptor antagonist activity of a naltrindole analogue with a regioisomeric indole moiety.
Portoghese PS; Ohkawa S; Moe ST; Takemori AE
J Med Chem; 1994 Jun; 37(12):1886-8. PubMed ID: 8021929
[TBL] [Abstract][Full Text] [Related]
10. Characterization of BU09059: a novel potent selective κ-receptor antagonist.
Casal-Dominguez JJ; Furkert D; Ostovar M; Teintang L; Clark MJ; Traynor JR; Husbands SM; Bailey SJ
ACS Chem Neurosci; 2014 Mar; 5(3):177-84. PubMed ID: 24410326
[TBL] [Abstract][Full Text] [Related]
11. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
[TBL] [Abstract][Full Text] [Related]
12. Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.
Stevens WC; Jones RM; Subramanian G; Metzger TG; Ferguson DM; Portoghese PS
J Med Chem; 2000 Jul; 43(14):2759-69. PubMed ID: 10893314
[TBL] [Abstract][Full Text] [Related]
13. delta Opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole.
Coop A; Rothman RB; Dersch C; Partilla J; Porreca F; Davis P; Jacobson AE; Rice KC
J Med Chem; 1999 May; 42(9):1673-9. PubMed ID: 10229636
[TBL] [Abstract][Full Text] [Related]
14. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist.
Portoghese PS; Sultana M; Takemori AE
Eur J Pharmacol; 1988 Jan; 146(1):185-6. PubMed ID: 2832195
[No Abstract] [Full Text] [Related]
15. Delta opioid receptor selective alkaloid agonists and antagonists.
Woods JH; DeCosta B; Jacobson AE; Rice KC; Medzihradsky F; Smith CB; Comer S; France CP; Winger G
NIDA Res Monogr; 1989; 95():300-1. PubMed ID: 2561836
[No Abstract] [Full Text] [Related]
16. Modulation of kappa-mediated antitussive activity in rats by a delta-agonist.
Kamei J; Tanihara H; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1992 Jun; 76(3):375-8. PubMed ID: 1321982
[TBL] [Abstract][Full Text] [Related]
17. Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes.
Portoghese PS; Sultana M; Nelson WL; Klein P; Takemori AE
J Med Chem; 1992 Oct; 35(22):4086-91. PubMed ID: 1331455
[TBL] [Abstract][Full Text] [Related]
18. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.
Gao P; Larson DL; Portoghese PS
J Med Chem; 1998 Jul; 41(16):3091-8. PubMed ID: 9685249
[TBL] [Abstract][Full Text] [Related]
20. The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist.
Tsuruda PR; Vickery RG; Long DD; Armstrong SR; Beattie DT
Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):479-91. PubMed ID: 23549670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
